Q4 2025 Inogen Inc Earnings Call Transcript
Key Points
- Inogen Inc (INGN) achieved a 4% year-over-year revenue growth in 2025, meeting their mid-single-digit growth target.
- The company reported a significant milestone by delivering positive adjusted EBITDA of $2.7 million for the first time since 2021.
- International sales were a bright spot, with a 15% year-over-year growth in Q4, driven by successful expansion into new geographies.
- Inogen Inc (INGN) has a strong balance sheet with $120.9 million in cash equivalents and no debt, providing financial flexibility for future investments.
- The company launched a $30 million share repurchase program, reflecting confidence in their strategy and commitment to enhancing shareholder value.
- Inogen Inc (INGN) experienced a shift in the timing of large customer orders from Q4 2025 to the first half of 2026, impacting revenue recognition.
- US sales declined by 5.1% in Q4 2025 compared to the prior year, primarily due to lower sales and rentals.
- Gross margin decreased by 220 basis points in Q4 2025, primarily due to a higher proportion of POC sales shifting to business customers.
- Rental revenue declined by 4.5% in Q4 2025, driven by a higher mix of lower private payer reimbursement rates and fewer patients on service.
- The company continues to face challenges in the direct-to-consumer channel, with a 15% decline in Q4 2025, although this is an improvement from previous quarters.
Welcome to Innogen's 4th quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ask a question at that time, please press star, followed by the number 1 on your touchtone phone.
If anyone has difficulty hearing the conference, please press 0 for operator assistance. As a reminder, this conference is being recorded today, February 24, 2026. I would now like to turn the call over to Lorna Williams, senior Vice President of Investor relations and strategic planning.
Thank you for participating in today's call. Joining me are President and CEO Kevin Smith and CFO Mike Burke. Earlier today, Inogen released financial results for the 4th quarter and full year 2025. The earnings release is available. In the investor relations section of the company's website along with a supplemental financial package, please note we have also published a new investor presentation on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
